Follow-up of children and young adults after GnRH-agonist therapy or central precocious puberty.
Feuillan
P P
PP
DEB, NICHD, NIH, Bethesda, MD 20892, USA. pfeuill@helix.nih.gov
Jones
J V
JV
Barnes
K
K
Klein
K O
KO
Cutler
G B
GB
D000293:Adolescent; D015992:Body Mass Index; D002648:Child; D004827:Epilepsy; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D005500:Follow-Up Studies; D012739:Gonadal Steroid Hormones / Q000097:blood; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D009765:Obesity; D010053:Ovary / Q000473:pathology / Q000503:physiopathology; D011629:Puberty, Precocious / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology / Q000523:psychology; D013737:Testis / Q000473:pathology / Q000503:physiopathology; D017329:Triptorelin Pamoate / Q000031:analogs & derivatives
D012739:Gonadal Steroid Hormones; D017329:Triptorelin Pamoate; D007987:Gonadotropin-Releasing Hormone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; C029256:histrelin; C066438:deslorelin